Tectonic Therapeutic initiates coverage with neutral rating and $26 target price
TECX•UBS initiated coverage of Tectonic Therapeutic with a neutral rating and a $26 target price.
Related News
FuelCell Energy appoints John Dansby as SVP, scale up manufacturing
FCEL•
Oil prices rise as attacks on Saudi Arabia overshadow Trump's diesel deal
USO•
APA Corporation: UBS raises target price to $52 from $47
APA•
Morgan Stanley cuts Nagarro voting rights stake to 6.79% from 8.18%
MS•
California Resources Corporation: UBS cuts target price to $68 from $73
CRC•